Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Myriad Asset Management is an investment management firm, not a life science, biotech, pharma, or healthcare operating company. The firm describes itself as a global macro investment manager and also manages the Myriad Dynamic Asset Allocation ETF. Public profiles indicate it provides investment advisory and portfolio management services through hedge fund and related investment vehicles. While the firm may invest in healthcare securities, it does not appear to develop therapeutics, diagnostics, medical devices, or healthcare services as its primary business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Myriad Asset Management.